Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ITBMed Receives $67 Million to Advance Possible Breakthrough Transplant Drug Siplizumab
ITBMed Receives $67 Million to Advance Possible Breakthrough Transplant Drug Siplizumab
ITBMed Receives $67 Million to Advance Possible Breakthrough Transplant Drug Siplizumab
Submitted by
admin
on April 4, 2018 - 9:53pm
Source:
CP Wire
News Tags:
ITBMed
organ transplants
siplizumab
immunosupression
Headline:
ITBMed Receives $67 Million to Advance Possible Breakthrough Transplant Drug Siplizumab
Do Not Allow Advertisers to Use My Personal information
